Bio-Techne/$TECH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bio-Techne
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Ticker
$TECH
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
3,100
ISIN
US09073M1045
Website
Bio-Techne Metrics
BasicAdvanced
$7.6B
58.23
$0.83
1.46
$0.24
0.66%
Price and volume
Market cap
$7.6B
Beta
1.46
52-week high
$83.62
52-week low
$46.01
Average daily volume
2.2M
Dividend rate
$0.24
Financial strength
Current ratio
3.707
Quick ratio
2.233
Long term debt to equity
20.29
Total debt to equity
20.986
Dividend payout ratio (TTM)
38.45%
Interest coverage (TTM)
13.77%
Management effectiveness
Return on assets (TTM)
5.05%
Return on equity (TTM)
6.53%
Valuation
Price to earnings (TTM)
58.23
Price to revenue (TTM)
6.319
Price to book
3.77
Price to tangible book (TTM)
12.51
Price to free cash flow (TTM)
34.603
Dividend yield (TTM)
0.50%
Forward dividend yield
0.66%
Growth
Revenue change (TTM)
4.72%
Earnings per share change (TTM)
-33.66%
3-year revenue growth (CAGR)
3.94%
3-year earnings per share growth (CAGR)
-15.44%
What the Analysts think about Bio-Techne
Analyst ratings (Buy, Hold, Sell) for Bio-Techne stock.
Bio-Techne Financial Performance
Revenues and expenses
Bio-Techne Earnings Performance
Company profitability
Bio-Techne News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bio-Techne stock?
Bio-Techne (TECH) has a market cap of $7.6B as of May 30, 2025.
What is the P/E ratio for Bio-Techne stock?
The price to earnings (P/E) ratio for Bio-Techne (TECH) stock is 58.23 as of May 30, 2025.
Does Bio-Techne stock pay dividends?
Yes, the Bio-Techne (TECH) stock pays dividends to shareholders. As of May 30, 2025, the dividend rate is $0.24 and the yield is 0.66%. Bio-Techne has a payout ratio of 38.45% on a trailing twelve-month basis.
When is the next Bio-Techne dividend payment date?
The next Bio-Techne (TECH) dividend payment is scheduled for May 30, 2025.
What is the beta indicator for Bio-Techne?
Bio-Techne (TECH) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.